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Available online 26 January 2016Regulated autophagy is a critical component for a healthy skeletal muscle mass, such that dysregulation of the
autophagic processes correlates with severe myopathies. Thus, defining the biological molecules involved in
the autophagic processes within skeletal muscle is of great importance. Here we demonstrate that globular
adiponectin (gAd) activates autophagy in skeletal muscle myoblasts via an AMPK-dependent mechanism. Acti-
vation of autophagy through gAd promotes myoblast survival and apoptosis inhibition during serum starvation
and the gAd-activated autophagy orchestrates themyogenic properties of the hormone. Consistentwith this con-
clusion, inhibition of gAd-activated autophagy by both a pharmacological (chloroquine) or siRNA approach
greatly inhibited muscle differentiation, as demonstrated by reductions in myosin heavy chain expression and
myotube formation. Further support for the role of adiponectin in autophagy comes from the skeletal muscles
of adiponectin KO mice which display decreased LC3 II expression and a myopathic phenotype (heterogeneous
fiber sizes, numerous central nuclei). Overall, these findings demonstrate that gAd activates autophagy in myo-
blasts and that gAd-activated autophagy drives the myogenic properties of this hormone.
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Autophagy1. Introduction
Autophagy is important for tissue homeostasis and for the clearance
of damaged organelles, misfolded proteins, and pathogens [21,24,27].
Well-regulated autophagy is fundamental for tissue health such that
dysregulated autophagy is observed in several human pathologies,
including muscle diseases [3,32]. In skeletal muscle, autophagy is sig-
nificantly enhanced in response to pro-atrophic stimuli such as dener-
vation [25], disuse [42], hypoxia [1], and aging [6]. Importantly,
autophagy reactivation has been demonstrated to greatly ameliorate
the phenotype of diseased muscles [14,15], making it essential, from a
therapeutic perspective, to improve the knowledge of the biological
molecules which can promote autophagy activation in skeletal muscle.
Relative to other hormones, adiponectin is one of themore abundant
circulating hormones and has been demonstrated to regulate glucose
and lipid homeostasis, as well as having anti-atherogenic and anti-
inflammatory properties [38]. Globular adiponectin (gAd), originated
from the full-length (fAd) form by proteolytic cleavage [35], carriesadiponectin; MYH, Muscularout crucial biological effects on different tissues including liver, skeletal
muscle, and endothelium. Alongside its well-defined metabolic effects
in skeletal muscle [39,40], gAd acts on different muscle cell populations
promoting muscle differentiation. In particular, gAd promotes
myogenesis inmyoblasts [10], satellite cells [11], and induces migration
and muscle differentiation in the non-resident muscle precursors,
mesoangioblasts [13].
Recently, an association between adiponectin and autophagy in
other cell populations has been reported [9,17,22,28,31], and given the
fundamental importance of autophagy in muscle health [4,6], we hy-
pothesized that gAd would be a key regulator of autophagy in skeletal
muscle and it's myoblast population. We report that gAd activates au-
tophagy on C2C12 myoblasts through an AMPK-dependent pathway.
Autophagy activation by gAd inhibits apoptosis in serum-deprived
(starved) conditions, thereby enhancing the differentiation of myo-
blasts toward myotubes. Interestingly, we demonstrate that autophagy
is a critical regulator of myoblast differentiation and that gAd, exoge-
nously administered or through paracrine-signaling from other myo-
blasts, is critical for autophagy regulation. These findings highlight
that gAd plays an integral role in autophagy activation in skeletal mus-
cle and it's progenitor cells. Furthermore, these findings support the in-
vestigation of adiponectin as a new tool for the amelioration of many
inherited muscle diseases which exhibit an inhibited autophagy.
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2.1. Materials
Unless specified, all reagents were obtained from Sigma. PVDF
membrane was from Millipore; anti-AMPK (sc-25792), anti-phospho-
Thr172-AMPK (sc-33524), anti-acrp30 (sc-26497), anti-Myosin Heavy
Chain (MYH) (sc-20641), anti-bcl-2 (sc-492), anti-bad (sc-943) anti-
bodies, acrp30 siRNA (sc-45891), AdipoR1 siRNA (sc-60124) were
from Santa Cruz; anti-LC3, anti-beclin-1, and Alexa 488 fluorescent
secondary antibodies were from Pierce. gAd was from Alexis. TACS
Annexin V-FITC Kit was from Trevigen. JC-1 probe was from Molecular
Probe.
2.2. Cell cultures
C2C12 myoblasts were cultured in growing medium composed of
Dulbecco's modified Eagle's medium supplemented with 10% fetal bo-
vine serum in 5% CO2 humidified atmosphere. For differentiation, sub-
confluent C2C12 were shifted from growing medium to differentiating
medium composed of Dulbecco modified Eagle's medium containing
2% Horse Serum (HOS) or gAd (1 μg/ml) for 4 days.
2.3. Differentiation and fusion indexes
The differentiation index is the percentage of MYH positive cells
above the total nuclei. The fusion index is the average number of nuclei
present in MYH positive cells containing at least three nuclei above the
total nuclei.
2.4. Apoptosis detection
Cells werewashed oncewith PBS buffer, detached from culture plate
and then collected by centrifugation at 1000 rpm for 5min. After awash
with PBS buffer, cells were centrifuged again and then annexin V and
propidium iodide positive cells were labeled following manufacturer's
instructions. The analysis of early and late apoptotic cellswasperformed
by flow cytometry.
2.5. MTT assay
0.5 mg/ml of 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2 H-
tetrazolium bromide (MTT) (Sigma–Aldrich, St. Louis, MO, USA) was
added to the cells. After 1 h at 37 °C, the cells were extensively washed
with PBS and then 1 ml of DMSO was added to the culture. The absor-
bance was measured at 570 nm wavelength.
2.6. Immunoblotting
Cells were lysed for 20 min on ice in 500 μl of complete radio-
immunoprecipitation assay (RIPA) buffer. Lysates were clarified
by centrifugation, and total protein contents were obtained using
Bradford assay. 20 μg of total proteins for each sample were separated
by SDS-PAGE and transferred onto PVDFmembranes. PVDFmembranes
were incubated in 2% milk, probed with primary antibodies, and
incubated with secondary antibodies conjugated with horseradish
peroxidase.
2.7. Immunofluorescence
6 × 104 C2C12 cells were grown on glass coverslips. Cells were then
washed with phosphate-buffered saline and fixed in 3% para-
formaldehyde for 20 min at 4 °C. Fixed cells were permeabilized with
three washes with TBST (50 mM Tris–HCl, pH 7.4, 150 mM NaCl, 0.1%
Triton X-100), and then blocked with 5.5% HOS in TBST for 1 h at
room temperature. Cells were then incubated with specific primaryantibodies, diluted 1:100 in TBS (50 mM Tris–HCl, pH 7.4, 150 mM
NaCl), overnight at 4 °C. Cells were then washed once with TBST and
once with TBST with 0.1% BSA and then incubated with secondary anti-
bodies (diluted 1:100) for 1 h at room temperature in TBSTwith 3% BSA.
After extensive washes in TBST, cells were mounted with glycerol
plastine. The analysis of mitochondrial potential was performed by
treating cellswith JC-1 probe (5 μM final) for 15min at 37 °C and imme-
diately observed. The fluorescence in all experiments was analyzed
using a confocal fluorescence microscope (Leica TCS SP5).
2.8. Adiponectin silencing
Specific silencing of adiponectin was performed by transfection of
C2C12 myoblasts with small-interfering-RNA (siRNA) using TransIT
Transfection Reagent according to the manufacturer's instruction.
Non-targeting siRNA (scramble) was used as a negative control.
2.9. Adiponectin KO mice
Ad-KO mice were generated as previously described [20]. Adult Ad-
KO andWTmice (6 months of age) were housed in standard cages and
had access to standard diet and water ad libitum. The animal room was
maintained at a constant temperature of 21 °C, a constant humidity of
50%, and a 12:12-h light–dark cycle. All experiments were approved
by the Animal Care Committee at York University and were conducted
in accordance with guidelines set forth by the Canadian Council for An-
imal Care.
2.10. Hematoxylin and eosin (H&E) staining
Cross-sections (8 μm thick) of gastrocnemious and soleus muscle
were cut on a cryostat andmounted on glass slides. Sections underwent
theH&E staining used for analyzingmorphological features for bothAd-
KO andWTmice. More than 100 fibers were analyzedwithin eachmus-
cle section.
2.11. Statistical analysis
Data are presented as mean ± S.D. from at least three in-
dependent experiments. Analysis of densitometry was performed
using ImageJ. Statistical analysis of the data was performed by Student's
t-test. P-values b0.05 were considered statistically significant.
3. Results
3.1. Activation of autophagy by gAd in myoblasts is an adapting response
leading to cell survival
Autophagy is a survival mechanism in response to starvation and
various stress conditions. A stress condition to which myoblasts must
undergo is the depletion of growth factors, a situation required for the
activation of the myogenic program. Our aim was to assay if gAd acti-
vates autophagy in myoblasts and define the involvement of gAd-
activated autophagy in the non-metabolic effects of the hormone in
myoblasts. Firstly, we observed that treatment of myoblasts with gAd
for 24 h promoted autophagy as shown by the increase of the autopha-
gic markers LC3 II and beclin-1 (Fig. 1A). In the same conditions, we ob-
served that the intracellular adiponectin level is unaffected by 24 h gAd
stimulationwhile an increased phosphorylation of Thr172 in AMPKwas
detected following gAd treatment (Fig. 1A). Once generated, LC3 II be-
comes a component of autophagosomes appearing as dots within the
cells. gAd increased the number of autophagosomes in myoblasts, as
shown by confocal analysis (Fig. 1B), while the use of the AMPK inhibi-
tor, Compound C, robustly decreased the number of autophagosomes
within the cells (Fig. 1B), thus showing that activation of autophagy
by gAd is AMPK-dependent. To accurately examine the autophagic
Fig. 1. gAd activates autophagy in myoblasts inducing cell survival. A) C2C12myoblastswere
serum-depleted overnight and then gAd (1 μg/ml) was added for 24 h. Cell lysates were
used for the detection of LC3 II, beclin-1, acrp30, and the phosphorylated Thr 172 of
AMPK. Bar graph shows the expression level of LC3 II, beclin-1, and acrp30 obtained
using actin for normalization and the phosphorylation level of AMPK reported as the
ratio between the phosphorylated and total AMPK. a.u.: arbitrary unit. B) Detection of
intracellular LC3 II by confocal microscopy. Cells were seeded on coverslips, serum-
depleted overnight and then stimulated with gAd (1 μg/ml) for 24 h. Compound C
(100 μM) or BAF A1 (100 nM) was added to the cells together with gAd. Cells were
fixed and treated with anti-LC3 antibodies and then with Alexa 488 secondary
antibodies (green). Propidium iodide was used for nuclei visualization (red). Bar graph
shows the mean of LC3 puncta per cell (100 cells/experiment examined). C) C2C12
myoblasts were serum-depleted overnight and then gAd (1 μg/ml) was added for 24 h.
MTT assay was performed as reported in “Material and methods” section. Values are
reported as fold increase vs the corresponding control (+gAd vs−gAd; + gAd and BAF
vs+BAF; + gAd and Compound C vs Compound C). ⁎p b 0.001; ⁎⁎p b 0.01.
Fig. 2. gAd protects myoblasts from apoptotic death through autophagy activation. A) C2C12
myoblasts were serum-depleted overnight and then gAd (1 μg/ml) was added for 24 h.
Percent of apoptotic cells reported in the bar graph considering 100% control cells (st or
st +BAF). BAF A1 (100 nM) were added to the cells together with gAd. The Y axis
shows the percentage of annexin V positive (+annexin) and propidium iodide positive
(+PI) cells. B) Analysis of bad and bcl-2 level by immunoblot. Expression of both
proteins are normalized using actin immunoblot and reported in the bar graph as
arbitrary unit (a.u.). ⁎p b 0.001. C) Analysis of mitochondrial potential using JC-1 probe.
Cells were seeded on coverslips, serum-depleted overnight and then gAd (1 μg/ml)
was added for 24 h. JC-1 probe (5 μM) was added to the cells for 15 min at 37 °C
and then immediately observed using confocal microscope. Shown experiments are
representative of four with similar results.
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(BAF) A1 which prevents the formation of the autophagolysosomes.
BAF markedly increased LC3 II level in myoblasts treated with gAd as
shown by confocal analysis (Fig. 1B). To test if gAd-activated autophagy
has pro-survival effects in myoblasts, we performed MTT assay and
quantified the viability of the cells maintained in starving medium,
with or without supplemented gAd, in the presence of BAF or Com-
pound C. Fig. 1C shows that gAd induced a 1.4-fold increase in cell via-
bility and that the increase was greatly affected by the treatment of
cells with the autophagy inhibitor BAF and the AMPK inhibitor Com-
pound C. Silencing of acrp30 or the receptor AdipoR1 leads to decreased
cell viability which was restored when gAd was added to acrp30-
silenced myoblasts (Suppl. Fig.1). These findings demonstrate that
gAd activates autophagy in myoblasts, and in turn, this increased au-
tophagic activity leads to cell survival.3.2. In myoblasts, gAd-activated autophagy is involved in gAd anti-
apoptotic effect
To evaluate if gAd-activated autophagy is involved in apoptosis inhi-
bition in myoblasts, autophagic flux was blocked by BAF and apoptosis
was analyzed by propidium iodide and Annexin V staining. As shown
in Fig. 2A, gAd induced a ~40% decrease in apoptotic cells in comparison
to controlwhile BAF treatment resulted in nodifference in apoptotic cell
number between groups (Fig. 2A). The anti-apoptotic effect by gAd is
due to intrinsic pathway activation since gAd stimulation leads to a
marked decrease of bad and a large increase in Bcl-2 (Fig. 2B). The anal-
ysis of themitochondria potential with JC-1 probe shows that the treat-
ment of myoblasts with gAd induces a change from green fluorescence
(typical of apoptotic cells) to red fluorescence (typical of viable cells)
(Fig. 2C), thus confirming that gAd protects myoblasts from apoptosis
acting on intrinsic pathway.
3.3. Activation of autophagy by gAd in myoblasts plays a key role for
differentiation
In muscle precursor cells, gAd induces different effects ranging from
metalloproteinase production, migration, apoptosis inhibition, and
myogenesis [11,13]. Migration of myoblasts is greatly activated by
gAd, as shown by wound healing assay (Suppl. Fig. 2). Surprisingly,
myoblast motility was greatly impaired when autophagy was inhibited
by chloroquine, even in the presence of gAd (Suppl. Fig. 2), indicating
that the gAd-enhanced myoblast migration is the result of gAd-
mediated autophagy. We observed the autophagic marker LC3 II and
beclin-1 markedly increased during muscle differentiation, thus sug-
gesting that myogenesis and autophagy are associated processes
(Fig. 3A). In agreement with our previous results [10], we observed
an increased adiponectin expression during muscle differentiation
(Fig. 3A). Since gAd promotes myogenesis in muscle precursor cells
[10,11,13], we then investigated the involvement of gAd-activated au-
tophagy in the pro-differentiating function of the hormone. Chronic
treatment of myoblasts with gAd visibly enhanced myotube formation
(Fig. 3B), and increased measures of differentiation and fusion indexes
Fig. 3. Inhibition of autophagy decreases differentiation of myoblasts. A) Subconfluent myoblasts was shifted from growing medium to differentiating medium for the period indicated.
Amount of beclin-1, LC3, MYH, and acrp30 was analyzed by immunoblot. The expression level of each protein was calculated as the ratio with actin expression and reported in the bar
graph as arbitrary unit (a.u.). ⁎p b 0.001 vs point 0; §p b 0.01 vs point 0; #p b 0.001 vs point 0. B) Confocal analysis of the differentiation of myoblasts in the presence of chloroquine or
BAF. Cells were seeded on coverslips and the growing medium was replaced with differentiation medium for 4 days. Where indicated gAd (1 μg/ml), chloroquine (10 μM final) or BAF
(100 nM) were added to the medium and maintained along the experiment. After 4 days of differentiation, cells were treated with anti-MYH antibodies and then with Alexa-488
secondary antibodies. Green color shows MYH expression while red color shows propidium iodide that labels the nuclei. C) Western blot analysis of MYH expression in cells treated as
described in B). Bar graph shows the level of MYH expression calculated using actin immunoblot for normalization and reported as arbitrary unit (a.u.). ⁎p b 0.001; ⁎⁎p b 0.0001.
D) Differentiation and fusion indexes calculated after 4 days of differentiation of myoblasts in the presence of gAd, chloroquine, and BAF. The indexes were calculated as reported in
“Materials and methods” section. ⁎p b 0.001; ⁎⁎p b 0.0001; ⁎⁎⁎p b 0.01. Shown experiments were repeated at least three times with the same results.
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tophagy by chloroquine or by BAF markedly decreased myogenesis in
gAd-treated myoblasts in comparison to untreated cells, as shown by
confocal analysis and MYH expression (Fig. 3B and C). In agreement,
the inhibition of autophagy by chloroquine or by BAF in gAd-treated
myoblasts induced a decrease of both differentiation and fusion indexes,
although a decrease of fusion index was observed in untreated myo-
blasts in the presence of chloroquine and BAF (Fig. 3C). Overall, these
findings show that activated autophagy by gAd is involved in differenti-
ation of myoblasts.
3.4. Silencing of endogenous acrp30 inhibits autophagy and muscle differ-
entiation and enhances apoptosis
Different tissues, ranging from adipose tissue to skeletalmuscle, pro-
duce adiponectin [7]. In particular, myotubes enhance the expression of
adiponectin in inflamed and oxidative conditions, thus leading to an au-
tocrine/paracrine loop of adiponectin secretion [8,10]. To further con-
firm the involvement of skeletal muscle produced adiponectin in
autophagy activation, we silenced endogenous adiponectin in myo-
blasts via siRNA. After starving the cells in serum-deprived medium
for 24 h, LC3 II and beclin-1 expression levels were analyzed. The trans-
fection of acrp30 siRNA into myoblasts successfully decreased endoge-
nous adiponectin expression (Fig. 4A). Interestingly, the reduction inadiponectin expression resulted in similar relative decreases in autoph-
agic marker expression (i.e. LC3 II and beclin-1 levels) and in Thr 172
phosphorylation of AMPK (Fig. 4A). In agreement with the protective
role on myoblasts, acrp30 silencing induced an increased expression
of bad concomitant with a strong decrease of Bcl-2 level, thus
supporting the hypothesis that acrp30 silencing promotes the induction
of apoptotic death in myoblasts (Fig. 4B). At the same time, promotion
of adiponectin-silencedmyoblasts towardmyotubes resulted in a virtu-
ally complete absence of MYH expression and myotube formation or
(Fig. 4C and D). In agreement with these observations, quantifications
of both fusion and differentiation indexeswere dramatically diminished
(Fig. 4E). Altogether, these findings reveal that skeletal muscle derived
adiponectin is involved in autophagy activation and apoptosis inhibition
in myoblasts and that endogenously produced hormone induces au-
tophagic processes which underlie the pro-myogenic properties of the
hormone.
3.5. The administration of gAd to acrp30-silenced myoblasts restores
autophagy and differentiation and inhibits apoptosis
After observing that the autocrine production of acrp30 affects au-
tophagy, apoptosis, and differentiation inmyoblasts, we testedwhether
this effect was reversible by adding gAd to acrp30-silenced myoblasts.
We observed that 24 h of gAd stimulation induced autophagy activation
Fig. 4. Silencing of endogenous acrp30 or AdipoR1 affects autophagy, apoptosis, and differentiation of myoblasts. A) Sub-confluent myoblasts were silenced for acrp30 expression and
differentiating medium was added to the cells together with transfection solution. After 4 days anti-LC3, anti-beclin-1, anti-p-Thr-AMPK, and anti-acrp30, immunoblots were
performed. B) Myoblasts were silenced for acrp30 and free-serum medium was added together with transfection solution. Anti-bad and anti-bcl-2 immunoblots were performed 72 h
after transfection. C) MYH and acrp30 immunoblot 4 days after acrp30 silencing during muscle differentiation. The experiment was performed as described in A). D) Confocal analysis
of the acrp30-silenced myoblasts during differentiationfor. Cells were seeded on coverslips and treated as described in panel A). After 4 days of differentiation, cells were treated with
anti-MYH antibodies and then with Alexa-488 secondary antibodies. Green color shows MYH expression and red color corresponds to propidium iodide for nuclei staining.
E) Differentiation and fusion indexes calculated after 4 days of differentiation of acrp30-silenced myoblasts. The indexes were calculated as reported in “Materials and methods”
section. In A), B), and C) panels, actin immunoblot was used for normalization, except for p-Thr-AMPK which was normalized using total AMPK level. The bar graphs show LC3 II,
beclin-1, p-Thr-AMPK, and acrp30 (in panel A); bad and bcl-2 (panel B); and MYH and acrp30 (in panel C) expression levels reported as arbitrary unit (a.u.). These experiments are
representative of at four different ones with similar results. ⁎p b 0.001; ⁎⁎p b 0.0001.
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(Fig. 5A). AdipoR1-silenced myoblasts showed a decreased level of
both beclin-1 and LC3 II in comparison to control (scramble) highlight-
ing that endogenous acrp30 is unable to activate autophagy due to the
lack of its receptor. In agreement, gAd stimulation failed to activate au-
tophagy in AdipoR1-silenced myoblasts (Fig.5A). The pro-apoptotic
protein bad was markedly increased in acrp30-silenced and AdipoR1-
silenced myoblasts, and as expected, gAd stimulation led to decreased
bad only in acrp30-silenced myoblasts (Fig. 5A). The inhibition of apo-
ptotic pathway in acrp30-silenced myoblasts following gAd addition
was confirmed by analyzing the mitochondrial membrane potential
(Fig. 5B). In agreement, differentiation of myoblasts was restored in
acrp30-silenced myoblasts following gAd administration (Fig. 5C).
Overall, these findings demonstrate that exogenous gAd reactivates au-
tophagy and differentiation and blocks apoptosis following a blockade
of autocrine production.3.6. Soleus and gastrocnemious muscles from adiponectin KO mice display
decreased autophagy and a myopathic phenotype
To verify, in vivo, the involvement of adiponectin in the activation of
autophagy within skeletal muscle, we analyzed LC3 II and beclin-1 ex-
pression in adiponectin KO mice. LC3 II and beclin-1 levels were mark-
edly decreased in both soleus and gastrocnemious muscles in KO mice
in comparison to wild type (Fig. 6A), thus showing that adiponectin de-
pletion greatly affects skeletal muscle autophagy in vivo. Given the im-
portance of muscle satellite cells and their progeny to the growth and
maintenance of skeletal muscle [5], we hypothesized that impaired au-
tophagy in myoblasts would impact their myogenic capacity and this
would manifest as a myopathy within the adiponectin KO mice. Histo-
logical analysis of wild-type and adiponectin KO muscles revealed
very heterogeneous myofiber sizes, necrotic fibers, and a significant in-
crease in the number of centrally located nuclei in gastrocnemious
Fig. 5. gAd stimulation in acrp30-silenced myoblasts re-establishes autophagy, differentiation and inhibition of apoptosis. A) Acrp30 and AdipoR1 was silenced inmyoblasts. Where indicated,
48 h from transfection gAd (1 μg/ml) was added to the cells for additional 24 h and then immunoblots were performed. B) Acrp30-silenced myoblasts were used for the analysis of
mitochondrial potential using JC-1 probe. Cells were seeded on coverslips, acrp30-silenced, and 48 h from transfection gAd (1 μg/ml) was added for 24 h. JC-1 probe (5 μM) was added
to the cells for 15 min at 37 °C and then immediately observed using confocal microscope. C) Acrp30 was silenced in myoblasts and differentiating medium was added to the cells at
the moment of transfection. After 4 days, anti-MYH and anti-acrp30 immunoblots were performed. The bar graphs in panels A and C show protein expression level calculated using
actin for normalization and reported as arbitrary unit (a.u.). ⁎p b 0.001 (siRNA acrp30 + gAd vs siRNA acrp30− gAd); ⁎⁎p b 0.001 (siRNA acrp30 + gAd vs siRNA acrp30− gAd);
⁎⁎⁎p b 0.01 (siRNA acrp30 + gAd vs siRNA acrp30− gAd); #p b 0.001 (siRNA AdipoR1− gAd vs scramble; siRNA AdipoR1 + gAd vs scramble); §p b 0.001 (siRNA acrp30− gAd vs
scramble); and p b 0.001 (siRNA AdipoR1 + gAd vs siRNA acrp30 + gAd); ##p b 0.001 (siRNA AdipoR1 + gAd vs siRNA acrp30 + gAd). §§p b 0.001 (siRNA acrp30 − gAd vs
scramble). Shown experiments are representative of four with similar results.
699T. Gamberi et al. / Biochimica et Biophysica Acta 1863 (2016) 694–702muscles of KO mice compared to wild-type (Fig. 6B and C). These find-
ings provide support for a strong correlation between adiponectin, au-
tophagy, and skeletal muscle health in vivo.
4. Discussion
In this paper, we describe the involvement of gAd in the activation of
autophagy in skeletal muscle myoblasts and the necessity for this pro-
cess in adult myogenesis, and ultimately, in skeletal muscle health.
We observed that i) gAd promoted autophagy in myoblasts in an
AMPK-dependent fashion; ii) activation of autophagy by gAd played a
key role for myoblast survival and apoptosis inhibition; iii) pharmaco-
logical inhibition of gAd-induced autophagy impaired survival and dif-
ferentiation of myoblasts; iv) silencing of endogenous adiponectin in
myoblasts reduces autophagy and cell survival and abrogates myoblast
differentiation; and finally, v) skeletal muscles of adiponectin KO mice
display decreased autophagy and characteristics of a generalizedmyop-
athy. Thus, we report the first study illustrating a deep correlation be-
tween autophagy and muscle health regulated by gAd.Recently, it was reported that administration of full-length
adiponectin to mice fed with high-fat diet promoted autophagy activa-
tion and improved the metabolic profile of these mice (including glu-
cose tolerance and insulin sensitivity) [23]. Our findings expand on
this work by demonstrating that autophagy inmyoblasts can be elicited
by both endogenous adiponectin and exogenous gAd, which is themore
active form of the hormone in skeletal muscle [39]. This is in agreement
with the main expression of AdipoR1 in muscle cells, the isoform of
adiponectin receptor to which gAd has the greatest affinity [39]. Fur-
thermore, we demonstrate that gAd–induced autophagy is associated
with adiponectin's myogenic roles [10], thus linking autophagy activa-
tion to the non-metabolic effect of gAd in muscle cells. Indeed, it is
now clear that adiponectin plays additional roles besides modulating
metabolism, among which is the participation in the regenerative pro-
cess in many tissues [12]. The involvement of adiponectin in activation
of autophagy has been reported in hepatic cells [29], colorectal cancer
cells [17], and in mice where adiponectin protects liver from toxicity
caused by acetaminophen overdose through an autophagic-dependent
mechanism [22].
Fig. 6. Analysis of adiponectin KOmuscles. A) Immunoblot analysis of LC3 II, beclin-1, and acrp30 expression level in soleus and gastrocnemious. Actin immunoblot is used for normalization.
The bar graphs show the ratio between the level of LC3 II, beclin-1, or acrp30 and actin reported as arbitrary units (a.u.). B) H&E staining of muscle cross-sections from wild-type and
adiponectin KO mice. White arrows indicate the central nucleated fibers. C) Percentage of central nuclei in WT and adiponectin KO mice.⁎p b 0.001.
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has previously been reported. For example, themuscle-specific deletion
of the autophagy gene, Atg7, induces significant muscle atrophy and an
age-dependent decrease in force [25]. Furthermore, a key role of au-
tophagy during differentiation has been reported for many tissues,
such as myofibroblast differentiation [2] and the cardiac differentiation
[19,41]. With respect to skeletal muscle, autophagy increases during
myoblast differentiation and activated autophagy protects differentiat-
ing myoblasts from apoptosis [26]. In agreement with the latter, our
present findings demonstrate that activation of autophagy by gAd
inhibits apoptosis and promotes survival in myoblasts during serum-
starvation conditions. Autophagy and apoptosis have functional
relationships that could lead to different or convergent final effects de-
pending on cellular setting. Under some circumstances, autophagy con-
stitutes a stress adaptation that avoids cell death by suppressing
apoptosis,whereas in other cellular conditions, it constitutes an alterna-
tive cell-death pathway [24]. In hepatocytes, gAd uses activation of au-
tophagy to protect cells from apoptosis induced by ethanol [29]. Here,
we report that inhibition of apoptosis through gAd-induced activation
of the autophagic pathway in myoblasts is essential for myogenesis.
This is in agreement with the fact that myogenesis requires the activa-
tion of a transcriptional program induced by removal of growth factors
and, at this stage, inhibition of cell death is essential to obtain optimal
muscle differentiation. Nutrient deprivation induces activation of au-
tophagy that is crucial for cell survival [24]. We show that gAd treat-
ment in a low nutrient condition provokes a further enhancement of
autophagy activation, thus leading to a great increase of viable
myoblasts.
Some papers underline the key role of Bcl-2 and beclin-1 in the re-
ciprocal regulation of apoptosis and autophagy. Autophagy activation
induced by serum deprivation was accompanied by an up-regulation
of Bcl-2 protein levels, thus suggesting that Bcl-2 may participate in
balancing the beneficial and detrimental effects of autophagy on cell
survival [37]. Moreover, in diabetic cardiomyocytes pharmacologicalactivation of AMPK stimulates JNK1-Bcl-2 signaling pathway and in-
duces the dissociation of Bcl-2–beclin-1 complex. This event normalizes
autophagy and decreases apoptosis [18]. Bcl-2–beclin-1 association is
regulated by ROCK1 that, phosphorylating Thr119 of beclin-1, leads to
disassembly of the beclin-1–Bcl-2 complex [16]. How gAd can balance
autophagy activation and apoptosis inhibition, thus leading tomyoblast
survival andmuscle differentiation, needs further investigation. Howev-
er, the involvement of gAd in the regulation of Bcl-2–beclin-1 associa-
tion may be hypothesized.
Autophagy activation by gAd occurs through AMPK activation.
The downstream cascade by activated AMPK leading to autophagy
was previously demonstrated in muscle both in vitro [32] and in vivo
[30]. These findings highlight AMPK as an important player in autopha-
gy activation in muscle. In this regard, our results propose gAd as a
physiological molecule able to activate autophagy in vivo through
AMPK activation.
Our findings demonstrate that the silencing of endogenous acrp30
or AdipoR1 leads to autophagic marker decrease and to bad protein in-
crease, suggesting that adiponectin autocrine production is important
for autophagy activation and apoptosis inhibition in myoblasts. More-
over, the silencing of AdipoR1 (which is the isoform receptor mainly
expressed in muscle cells and for which gAd has greater affinity [39])
suggests that myoblasts probably produce gAd in this condition. In
this regard, gAd is not considered the circulating form of the hormone,
since acrp30 circulates in the plasma as low-, medium-, and high-mo-
lecular-weight aggregates of full-length form [34]. Even if it is reported
that gAd is produced locally in inflamed microenvironment [8,10], gAd
production in basal/not inflamed condition could not be excluded to
date.
The involvement of adiponectin inmuscle health is supported by our
previous results showing that the ex vivo treatment with gAd protects
mesoangioblasts from in vivo apoptosis, leading to increased engraft-
ment of the cells in the muscles of dystrophic mice [13]. For the first
time, we report a strong association in vivo between adiponectin,
701T. Gamberi et al. / Biochimica et Biophysica Acta 1863 (2016) 694–702autophagy, and muscle morphology based on the observations of
adiponectin KO mice.
Furthermore, myoblast motility is a key process during growth
or following damage to allow myoblasts to migrate to sites where
they are needed. In accordance with our previous findings showing
that gAd elicits a motile program in satellite cells [11] and in
mesoangioblasts [13], we report that gAd elicits a motile program in
myoblasts through a mechanism dependent on autophagy activation.
Protein degradation in skeletal muscle is controlled by the two
major proteolytic systems, the ubiquitin–proteasome and the autopha-
gy–lysosome systems. As far as autophagy is concerned, this process
must be finely regulated since dysregulated autophagy negatively af-
fectsmuscle health. Indeed, excessive activation of autophagy correlates
with muscle wasting [36,42] while inhibition of autophagy causes my-
opathies like Pompe and Danon diseases and worsens Duchenne and
Ulrich congenital muscular dystrophies [33] and Bethlem myopathy
[14]. Reactivation of autophagy ameliorates myopathic conditions,
highlighting the importance of autophagy for overall skeletal muscle
health [14,15].
Taken together, our findings demonstrate that both exogenous addi-
tion of gAd and endogenously produced hormone activates autophagy
in myoblasts and this activation, mediated through AMPK, orchestrates
downstream effects such as muscle differentiation, thus revealing a
clear hierarchy between these processes. Based on the key role of au-
tophagy in muscle health and since autophagy dysregulation greatly
correlateswith severemyopathies, the knowledge of the biologicalmol-
ecules able to activate autophagy can represent a new tool to ameliorate
myopathic conditions and gAd could be considered a good candidate for
this aim.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2016.01.016.
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